Initial Characteristics, Treatment and Prognosis »
04/09/14

Mapping The HLA Ligandome Of Chronic Lymphocytic Leukemia a€“ Towards Peptide Based Immunotherapy »
04/09/14

Influence Of Antithymoglobulin Doses On The Outcome Of Hematopoietic Stem Cells Transplantations After a Flu-Bu2 Conditioning Regimen: A Retrospective Study On 168 Consecutive Patients »
04/09/14

Controlled Epstein-Barr Virus Reactivation EBV-R After Allogenic Transplantation Improves Survival and Is Associated To An Expansion Of Natural Killer Cells (NK) »
04/09/14

Incidence and Risk Factors For Veno-Occlusive Disease Of The Liver After Allogeneic Stem Cell Transplantation Using a Reduced Intensity Regimen »
04/09/14

PI3KI´ Inhibitor Idelalisib Inhibits AKT Signaling In Myelofibrosis Patients On Chronic JAK Inhibitor Therapy »
04/09/14

Update On The Safety and Efficacy Of The Pan Class I PI3K Inhibitor SAR245408 (XL147) In Chronic Lymphocytic Leukemia and Non-Hodgkina€™s Lymphoma Patients »
04/09/14

PKC Inhibitor AEB071 Demonstrates Pre-Clinical Activity In Chronic Lymphocytic Leukemia »
04/09/14

Inhibitors Of B-Cell Receptor Molecules Affect Surface CD20 and Impair Antitumor Activity Of Anti-CD20 Monoclonal Antibodies »
04/09/14

ZAP70 Methylation Is An Independent Prognostic Biomarker For Front Line Therapy Of Chronic Lymphocytic Leukemia: Results From The UK LRF CLL4 Trial »
04/09/14